A deep learning model trained on more than 1.5 million electrocardiograms can reliably detect hyperkalemia—or abnormally high potassium levels in the blood—among patients with chronic kidney disease (CKD), Mayo Clinic researchers reported April 3 in JAMA Cardiology.

Electrocardiograms (ECG) acquired using a chest strap could be a quality alternative to traditional ECGs when used to diagnose atrial fibrillation (AF), researchers reported in the American Journal of Cardiology.

Another smartwatch has received FDA clearance for an electrocardiogram (ECG) feature. But this one—the Study Watch from Alphabet’s health division, Verily—is a “prescription-only device” rather than a product marketed to all consumers.

Cardiologs co-founder and CEO Yann Fleureau was named the European Innovator of the Year by MIT Technology Review. The company offers a cloud-based artificial intelligence (AI) platform that enables the detection of 14 cardiac arrhythmias through ambulatory electrocardiogram (ECG) readings.

The U.S. Preventive Task Force (USPSTF) issued a Grade I recommendation, indicating there is insufficient evidence assessing the benefits and harms of screening for atrial fibrillation (AFib) with electrocardiography (ECG) in patients 65 and older with previously undiagnosed AFib.

Patients without electrocardiographic (ECG) evidence of left ventricular hypertrophy were significantly more likely to die in the two years after transcatheter aortic valve replacement (TAVR), researchers reported July 30 in Clinical Cardiology.

Individuals at high risk for atrial fibrillation (AFib) who utilized a home-based wearable electrocardiogram (ECG) patch had a higher rate of AFib diagnosis after four months compared to delayed monitoring.

The U.S. Preventive Services Task Force (USPSTF) issued a Grade D recommendation against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease events in asymptomatic adults at low risk of CVD events.